ANN ARBOR, Mich.—Accuri Cytometers Inc., a developer of benchtop flow cytometer systems, has paired with eBioscience, a supplier of research flow cytometry reagents, to offer scientists a more comprehensive solution for their flow cytometry research needs. The partnership, comprised of a worldwide comarketing agreement, combines Accuri's C6 Flow Cytometer System and eBioscience's line of high-quality cytometer research reagents. Further terms of the agreement were not disclosed.

"The adoption of the Accuri C6 Flow Cytometer System by over 500 research labs for an increasing range of applications has brought the need for high-quality reagents that work seamlessly with our systems to the fore," says Jack Ball, chief commercial officer at Accuri. "This marketing partnership allows Accuri to further deliver on our promise to our customers to offer an affordable, easy-to-use flow cytometer solution—now made even more accessible with the easy availability of a full range of quality research reagents."